These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9568827)

  • 1. Prevention of aluminium exposure through dialysis fluids. Analysis of changes in the last 8 years.
    Fernández-Martín JL; Canteros A; Serrano M; González-Carcedo A; Díaz-Corte C; Cannata Andía JB
    Nephrol Dial Transplant; 1998; 13 Suppl 3():78-81. PubMed ID: 9568827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of the aluminum concentration in the final dialysis solution: Multicenter study in Spanish dialysis centers].
    Fernández Martín JL; Cannata JB
    Nefrologia; 2000; 20(4):342-7. PubMed ID: 11039259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF; D'Haese PC; Lamberts LV; Djukanovic L; Pejanovic S; Goodman WG; De Broe ME
    Clin Nephrol; 1998 Aug; 50(2):69-76. PubMed ID: 9725776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum aluminium level in the veneto chronic haemodialysis population: cross-sectional study on 1,026 patients.
    Piccoli A; Andriani M; Mattiello G; Nordio M; Modena F; Dalla Rosa C
    Nephron; 1989; 51(4):482-90. PubMed ID: 2787000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma aluminium: a redundant test for patients on dialysis?
    Gault PM; Allen KR; Newton KE
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):51-4. PubMed ID: 15802033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aluminium in water for preparation of dialysate and in serum of dialysed patients.
    Blanusa M; Prester L; Crnogorac M; Puretić Z; Bubić-Filipi L; Dadić Z
    Arh Hig Rada Toksikol; 1997 Jun; 48(2):197-204. PubMed ID: 9434431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adequacy of dialysis: trace elements in dialysis fluids.
    D'Haese PC; De Broe ME
    Nephrol Dial Transplant; 1996; 11 Suppl 2():92-7. PubMed ID: 8804004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative roles of intestinal absorption and dialysis-fluid-related exposure in the accumulation of aluminium in haemodialysis patients.
    Mazzaferro S; Perruzza I; Costantini S; Pasquali M; Onorato L; Sardella D; Giordano R; Ciaralli L; Ballanti P; Bonucci E; Cinotti GA; Coen G
    Nephrol Dial Transplant; 1997 Dec; 12(12):2679-82. PubMed ID: 9430871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aluminium in chronic renal replacement therapy patients undergoing haemodialysis in two renal units in Bogotá].
    Cárdenas O; Segura O; Puentes W; Sanabria M; Nava G; Torrenegra R
    Rev Salud Publica (Bogota); 2010 Aug; 12(4):669-81. PubMed ID: 21340131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response relationships in aluminium toxicity in humans.
    Coulson JM; Hughes BW
    Clin Toxicol (Phila); 2022 Apr; 60(4):415-428. PubMed ID: 35179097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrate anticoagulation and adverse events.
    De Vos J; Hombrouckx R
    EDTNA ERCA J; 2003; 29(3):112-3, 117. PubMed ID: 14552082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silicon and aluminium interactions in haemodialysis patients.
    Parry R; Plowman D; Delves HT; Roberts NB; Birchall JD; Bellia JP; Davenport A; Ahmad R; Fahal I; Altmann P
    Nephrol Dial Transplant; 1998 Jul; 13(7):1759-62. PubMed ID: 9681724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of aluminium intoxication in long-term acetate Redy dialysis.
    Van de Vyver FL; Visser WJ; D'Haese PC; Silva FJ; Thomas H; De Broe ME
    Nephrol Dial Transplant; 1989; 4(6):555-62. PubMed ID: 2507978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminium and nickel in human albumin solutions.
    Gammelgaard B; Sandberg E
    J Trace Elem Electrolytes Health Dis; 1989 Mar; 3(1):39-42. PubMed ID: 2535318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolution of the serum aluminum values in the Piedmont dialysis population. Dialysis Centers of the Piedmont].
    Fidelio T; Licata C; Serra A; Scalzo B; Deabate MC; Sancipriano GP; Iacono G; Calitri V
    Minerva Urol Nefrol; 1994 Mar; 46(1):73-6. PubMed ID: 8036558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of serum aluminium levels for bone accumulation in haemodialyzed patients.
    Costantini S; Giordano R; Vernillo I; Piccioni A; Zapponi GA
    Ann Ist Super Sanita; 1989; 25(3):457-61. PubMed ID: 2624356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of serum aluminium monitoring in dialysis patients: a multicentre study.
    D'Haese PC; Clement JP; Elseviers MM; Lamberts LV; Van de Vyver FL; Visser WJ; De Broe ME
    Nephrol Dial Transplant; 1990; 5(1):45-53. PubMed ID: 2109284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect on serum aluminium levels of continued ingestion of aluminium gels by patients with chronic renal insufficiency (author's transl)].
    Boukari M; Rottembourg J; Jaudon MC; Clavel JP; Legrain M; Galli A
    Nouv Presse Med; 1978 Jan; 7(2):85-8. PubMed ID: 349501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aluminium toxicity during regular haemodialysis.
    Elliott HL; Dryburgh F; Fell GS; Sabet S; Macdougall AI
    Br Med J; 1978 Apr; 1(6120):1101-3. PubMed ID: 638617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.